163 related articles for article (PubMed ID: 11888529)
1. Haptoglobin phenotype and coronary artery collaterals in diabetic patients.
Hochberg I; Roguin A; Nikolsky E; Chanderashekhar PV; Cohen S; Levy AP
Atherosclerosis; 2002 Apr; 161(2):441-6. PubMed ID: 11888529
[TBL] [Abstract][Full Text] [Related]
2. Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery Disease.
Asleh R; Levy AP; Levy NS; Asleh A; Goldenstein H; Segol I; Gulati R; Lerman LO; Lerman A
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):774-786. PubMed ID: 30727751
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation.
Roguin A; Ribichini F; Ferrero V; Matullo G; Herer P; Wijns W; Levy AP
Am J Cardiol; 2002 Apr; 89(7):806-10. PubMed ID: 11909563
[TBL] [Abstract][Full Text] [Related]
4. Haptoglobin genotype and its role in diabetic cardiovascular disease.
Costacou T; Levy AP
J Cardiovasc Transl Res; 2012 Aug; 5(4):423-35. PubMed ID: 22447230
[TBL] [Abstract][Full Text] [Related]
5. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Asleh R; Levy AP
Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
[TBL] [Abstract][Full Text] [Related]
7. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin phenotype and vascular complications in patients with diabetes.
Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
[No Abstract] [Full Text] [Related]
9. Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort.
Levy AP; Larson MG; Corey D; Lotan R; Vita JA; Benjamin EJ
Atherosclerosis; 2004 Feb; 172(2):361-5. PubMed ID: 15019547
[TBL] [Abstract][Full Text] [Related]
10. Relationship between pressure-derived collateral blood flow and diabetes mellitus in patients with stable angina pectoris: a study based on coronary pressure measurement.
Nişanci Y; Sezer M; Umman B; Yilmaz E; Mercanoğlu S; Ozsaruhan O
J Invasive Cardiol; 2002 Mar; 14(3):118-22. PubMed ID: 11870265
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis--haptoglobin genotype and diabetic nephropathy.
Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
[TBL] [Abstract][Full Text] [Related]
12. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S
Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.
Costacou T; Secrest AM; Ferrell RE; Orchard TJ
Diab Vasc Dis Res; 2014 Sep; 11(5):335-42. PubMed ID: 24994788
[TBL] [Abstract][Full Text] [Related]
14. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Costacou T; Ferrell RE; Orchard TJ
Diabetes; 2008 Jun; 57(6):1702-6. PubMed ID: 18332093
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
Levy AP; Hochberg I; Jablonski K; Resnick HE; Lee ET; Best L; Howard BV;
J Am Coll Cardiol; 2002 Dec; 40(11):1984-90. PubMed ID: 12475459
[TBL] [Abstract][Full Text] [Related]
16. Association of the genetic variant rs2000999 with haptoglobin and diabetic macrovascular diseases in Chinese patients with type 2 diabetes.
Wang S; Zhang R; Wang T; Jiang F; Hu C; Jia W
J Diabetes Complications; 2019 Feb; 33(2):178-181. PubMed ID: 30366827
[TBL] [Abstract][Full Text] [Related]
17. Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene.
Levy AP
Acta Diabetol; 2003 Dec; 40 Suppl 2():S330-3. PubMed ID: 14704863
[TBL] [Abstract][Full Text] [Related]
18. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
[TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of coronary collaterals in diabetic and nondiabetic patients by angiography.
Islam MM; Ali A; Khan NA; Rahman A; Majumder AS; Chowdhury WA; Faruque GM; Faruque M; Jalaluddin M
Mymensingh Med J; 2006 Jul; 15(2):170-5. PubMed ID: 16878099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
